TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014
TCL Archive FDA seeks support for reorganization of cancer programs, but debate continues. July 9, 2004
TCL Archive NCI Chips In $2 Million For AACR Meeting; Advisors, Senior Staff Not Consulted. June 20, 2003